Psychiatric Manifestations Associated With Behcet's Disease

NCT ID: NCT04585360

Last Updated: 2020-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-10

Study Completion Date

2021-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The psychoBehçet'study is aimed at evaluating the psychological and neurocognitive symptoms in 25 consecutive patients followed for Behçet's disease. This is a monocentric, observational, non interventional study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be evaluated during a day-care facility for Behçet's disease activity together with evaluation of anxiety and depression symptoms (SCL90-R and MINI assessments), fatigue (MFI) and quality of life (SF36).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behçet's Disease, neuroBehcet, Anxiety, Depression, Tiredness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with Behcet disease

adult patient with Behcet's disease followed regularly in the internal medicine department of Bicetre

Questionnaires evaluating anxiety and depression symptoms, tiredness, and quality of life

Intervention Type OTHER

Realization of specific questionnaires evaluating:

* psychiatric symptoms (self-assessment according to the SLC-90R questionnaire and hetero-assessment by the internist doctor of the center according to the M.I.N.I. questionnaire)
* fatigue (Multidimensional Fatigue Inventory (MFI-20), French version, in self-assessment)
* quality of life (SF36 self-assessment questionnaire)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires evaluating anxiety and depression symptoms, tiredness, and quality of life

Realization of specific questionnaires evaluating:

* psychiatric symptoms (self-assessment according to the SLC-90R questionnaire and hetero-assessment by the internist doctor of the center according to the M.I.N.I. questionnaire)
* fatigue (Multidimensional Fatigue Inventory (MFI-20), French version, in self-assessment)
* quality of life (SF36 self-assessment questionnaire)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult male or female
* Regular follow-up in the internal medicine department of Bicetre hospital
* Diagnosed with Behçet's disease

Exclusion Criteria

* Refusal to participate in the study
* Poor command of the French language
* Patients under legal protection
* Pregnant woman
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

NOEL NN Nicolas, MD PhD

Role: PRINCIPAL_INVESTIGATOR

APHP, Hôpital Bicetre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Internal medecine department

Le Kremlin-Bicêtre, Val De Marne, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicolas NN NOEL, MD PhD

Role: CONTACT

+ 33 1 45 21 27 57

Fanny FU URBAIN, MD

Role: CONTACT

+ 33 1 45 21 27 57

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nicolas NOEL, MD, PhD

Role: primary

+ 331 45 21 27 57

Fanny URBAIN, MD

Role: backup

+ 33 1 45 21 27 57

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A01819-48

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Psychiatric Comorbidity
NCT02927652 COMPLETED